Healthcare Medical Homecare Products and Services
Andreas Rudolph, CEO
Patrick Arndt, CFO
Chairman of the Board
GHD's homecare business provides services in combination with the provision of consumable medical devices that require personal consultation and explanation. GHD does this through an unparalleled network of approximately 1,000 nurses and trained medical staff working in eight branches across Germany. In addition, GHD is a leading producer of custom-made infusion solutions for cytostatic drugs and parenteral nutrition. The company operates through a network of certified state-of-the-art production facilities across Germany.
Nordic Capital Fund VIII acquired a majority stake in GHD in 2014 and will support the company to enable continued accelerated growth, both organically and through acquisitions, within existing homecare and adjacent healthcare segments, as well as by developing new business areas.
EUR 610 million
Nordic Capital Fund VIII, controlling shareholding